Sökresultat - T. T. Valiev
- Visas 1 - 20 av 105 resultat
- Gå till nästa sida
-
1
CLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF PEDIATRIC RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMAS av T. T. Valiev
Publicerad 2018-07-01Despite the development and active use of modern high-effective therapeutic protocols for pediatric non-Hodgkin’s lymphomas (NHL), treatment results of relapses and refractory disease are unsatisfactory. In the current issue international practices and own experience in relapsed/refractory pediatric...
Hämta fulltext
Artikel -
2
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment av T. T. Valiev
Publicerad 2023-09-01Currently no therapy of acute lymphoblastic leukemia is conceivable without L-asparaginase drugs, with its antileukemic effect by extracellular asparagine depletion, thus preventing its admission to leukemic cell. Besides high antitumor effect, L-asparaginase drugs have side and toxic effects, such...
Hämta fulltext
Artikel -
3
Diagnostic and therapeutic approaches for lymphoblastic lymphomas from progenitor cells in children and adolescents av T. Yu. Pavlova, T. T. Valiev
Publicerad 2023-12-01Lymphoblastic lymphomas (LBL) are the second most common subtype of non-Hodgkin’s lymphomas in children and adolescents, accounting for 25–35 % of all non-Hodgkin’s lymphomas cases. The majority of all lymphoblastic lymphomas (80–85 %) are T-lymphoblastic origin; 15–20 % origins from B-cell precurso...
Hämta fulltext
Artikel -
4
Differentiated, immunobased approach of anaplastic large cell lymphoma treatment in children and adolescents: literature review and protocol ALCL-NII DOG-2003 results av A. S. Volkova, T. T. Valiev
Publicerad 2023-05-01Background. Anaplastic large cell lymphoma (ALCL) is a rare variant of highly aggressive lymphomas in children and adolescents. ALCL is characterized by a heterogeneous clinical manifestation with nodal and extranodal lesions, various morphological variants, variable expression of T-cell markers and...
Hämta fulltext
Artikel -
5
Current trends in pediatric aggressive B-cell lymphomas treatment av Yu. S. Korkina, T. T. Valiev
Publicerad 2021-06-01Nowadays due to modern risk-adapted treatment protocols high survival rates have been achieved in patients with aggressive B-cell lymphomas, even at stages III–IV these indicators overrun 90 %. Mainly these successes were associated with the inclusion of rituximab in the standard chemotherapy regime...
Hämta fulltext
Artikel -
6
Results of longstanding, single-center trial for pediatric Hodgkin lymphoma treatment av T. T. Valiev, E. S. Belyaeva
Publicerad 2021-09-01Background. Actually, treatment results of Hodgkin lymphoma (HL) are the most dramatic oncohematology achievements, therefore modern treatment protocols designed to toxicity reduction with the same high level of patients’ survival. Time of complete response occupies a central position in the prognos...
Hämta fulltext
Artikel -
7
Priapism as the first symptom of chronic myeloid leukemia: literature review and own clinical case report av T. Yu. Pavlova, T. T. Valiev
Publicerad 2022-11-01Chronic myeloid leukemia is a ph-positive myeloproliferative disease, which is usually manifested by hyperleukocytosis and massive splenomegaly. Chronic myeloid leukemia is rare in childhood and adolescence, it accounts for 2 to 3 % of all leukemias cases. priapism is a rare manifestation of chronic...
Hämta fulltext
Artikel -
8
L-asparaginase: New about Well-Known Drug av Yuliya S. Korkina, Timur T. Valiev
Publicerad 2021-07-01The history of asparaginase clinical use is inextricably linked to the improvement of treatment programs for acute lymphoblastic leukaemia (ALL). Asparaginase, obtained from E. coli, has become the crucial part in the protocols for the treatment of ALL in children and adults since the 1960s-1970s du...
Hämta fulltext
Artikel -
9
Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease av M. A. Shervashidze, T. T. Valiev
Publicerad 2020-10-01Treatment of acute lymphoblastic leukemia (ALL) in children during the last 50 years has changed significantly, which has increased the survival of patients from 10–15 % in the early 60s to 80–85 % by the mid-2000s. Such results have been achieved through the development of new polychemotherapy regi...
Hämta fulltext
Artikel -
10
Pediatric acute myeloid leukemias treatment: current scientific view av F. A. Makhacheva, T. T. Valiev
Publicerad 2020-04-01The results of treatment of acute myeloid leukemias (AML) in children remain unsatisfactory. Modern therapeutic programs with hematopoietic stem cell transplantation allow us to get 5-year overall survival rate of 65 % in primary patients. For patients with relapses or refractory AML, 5-year overall...
Hämta fulltext
Artikel -
11
Treatment of pediatric relapsed and refractory acute myeloid leukemia av F. A. Makhacheva, T. T. Valiev
Publicerad 2023-05-01Background. Despite the modern therapy programs including hematopoietic stem cell transplantation, the treatment outcomes for children with acute myeloid leukemia (AML) remain unsatisfactory. The 5‑year overall survival rate is about 70 %. The 5‑year overall survival rate for patients with relapsed...
Hämta fulltext
Artikel -
12
The administration of PD-1 and PD-L1 inhibitors in pediatric hematology: a literature review av Aleksandra S. Paderina, Timur T. Valiev
Publicerad 2024-07-01The discovery of immune checkpoints (IC) has become a landmark event in immuno-oncolog y, improving the understanding of the mechanisms of tumor cells evading immune sur veillance. Based on this, a group of drugs such as immune checkpoint inhibitors (ICIs) were developed, the ef fect of which is due...
Hämta fulltext
Artikel -
13
Clinical features of secondary acute myeloid leukemia in children av F. A. Makhacheva, T. T. Valiev
Publicerad 2020-12-01Background. Secondary malignancies in pediatric cancer survivors is an actual problem in modern oncopediatry. Alkylating agents and topoisomerase II inhibitors used for primary tumors treatment, induce secondary acute myeloid leukemia (sAML), which treatment results are unsatisfactory.Objective. By...
Hämta fulltext
Artikel -
14
Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002 av T. T. Valiev, M. A. Shervashidze, T. S. Belysheva
Publicerad 2022-07-01Background. Treatment results of acute lymphoblastic leukemia in children on protocol, developed by one of the leading research study group BFM (Berlin-Frankfurt-Munster) are impressive - longstanding overall survival rate comprise 93.4 %. The basis of success is a differential approach based on pro...
Hämta fulltext
Artikel -
15
Clinical and molecular-biologic features of infant acute leukemia av Y. S. Korkina, T. T. Valiev, S. R. Varfolomeeva
Publicerad 2022-04-01Acute leukemia (AL) in children up 1 year old is very rare disease, comprise less 5 % of all pediatric AL cases. The clinical course of infant AL is extremely aggressive with frequent extramedullar dissemination, initial hyperleukocytosis and MLL aberrations. Predominance of unfavorable clinical and...
Hämta fulltext
Artikel -
16
On complexity of veri¯cation of nondeterministic probabilistic multiagent systems av M. K. Valiev, M. I. Dekhtyar
Publicerad 2010-12-01Probabilistic systems of interacting nondeterministic intelligent agents are consid- ered. States of the agents in these systems are some probabilistic databases, and the activity of the agents is controlled by some probabilistic logic programs. Moreover, com- munication channels between agents are...
Hämta fulltext
Artikel -
17
Productivity and grain quality of winter bread wheat varieties in the irrigated zone of the Republic of Dagestan when using biological products av T. R. Valiev, S. A. Kurbanov, D. S. Magomedova
Publicerad 2023-11-01In the conditions of the Terek-Sulak lowland of the Republic of Dagestan, we studied the effect of biological products on productivity and grain quality of winter bread wheat varieties developed by the National Grain Center namedafter P.P. Lukyanenko and the North Caucasus Federal Scientific Agraria...
Hämta fulltext
Artikel -
18
“Aliyevedenie” as a scholarly phenomenon av N. G. Valiev, A. G. Shorin
Publicerad 2023-05-01The centenary of the birth of Heydar Aliyev, a Soviet and Azerbaijani politician (1923—2003), prompted us to show interest in the personality of G. Aliyev, as well as in the study of the phenomenon of Aliyev studies — a unique interdisciplinary direction in the modern scientific environment of Azerb...
Hämta fulltext
Artikel -
19
Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case av Timur T. Valiev, Tatyana S. Belysheva, Svetlana R. Varfolomeeva
Publicerad 2020-12-01Background. Anaplastic large cell lymphoma (ALCL) represents 15% of all non-Hodgkin lymphomas (NHL) in children, and it is characterized by aggressive course and involvement of various organs and systems (including skin) in the pathological process. Skin tumors at NHL in childhood are rare. Thus, ca...
Hämta fulltext
Artikel -
20
Histiocytic neoplasms: modern aspects of pathogenesis, classification, diagnosis and treatment av O. D. Gurieva, T. T. Valiev, A. I. Pavlovskaya
Publicerad 2022-01-01Histiocytic cell tumors present as a difficult group of diseases in terms of differential diagnosis due to their rare frequency, heterogeneous clinical manifestations and ambiguous clinical course. Considering MAPK-signaling pathway mutations role (including BRAFV600E) in the pathogenesis of histioc...
Hämta fulltext
Artikel